Literature DB >> 19185184

Myotonia congenita.

Christoph Lossin1, Alfred L George2.   

Abstract

Myotonia is a symptom of many different acquired and genetic muscular conditions that impair the relaxation phase of muscular contraction. Myotonia congenita is a specific inherited disorder of muscle membrane hyperexcitability caused by reduced sarcolemmal chloride conductance due to mutations in CLCN1, the gene coding for the main skeletal muscle chloride channel ClC-1. The disorder may be transmitted as either an autosomal-dominant or recessive trait with close to 130 currently known mutations. Although this is a rare disorder, elucidation of the pathophysiology underlying myotonia congenita established the importance of sarcolemmal chloride conductance in the control of muscle excitability and demonstrated the first example of human disease associated with the ClC family of chloride transporting proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19185184     DOI: 10.1016/S0065-2660(08)01002-X

Source DB:  PubMed          Journal:  Adv Genet        ISSN: 0065-2660            Impact factor:   1.944


  43 in total

1.  Botulinum toxin in myotonia congenita: it does not help against rigidity and pain.

Authors:  Dirk Dressler; Fereshte Adib Saberi
Journal:  J Neural Transm (Vienna)       Date:  2013-12-20       Impact factor: 3.575

Review 2.  Guidelines on clinical presentation and management of nondystrophic myotonias.

Authors:  Bas C Stunnenberg; Samantha LoRusso; W David Arnold; Richard J Barohn; Stephen C Cannon; Bertrand Fontaine; Robert C Griggs; Michael G Hanna; Emma Matthews; Giovanni Meola; Valeria A Sansone; Jaya R Trivedi; Baziel G M van Engelen; Savine Vicart; Jeffrey M Statland
Journal:  Muscle Nerve       Date:  2020-05-27       Impact factor: 3.217

Review 3.  Mutational consequences of aberrant ion channels in neurological disorders.

Authors:  Dhiraj Kumar; Rashmi K Ambasta; Pravir Kumar
Journal:  J Membr Biol       Date:  2014-08-14       Impact factor: 1.843

4.  Mapping ligand binding pockets in chloride ClC-1 channels through an integrated in silico and experimental approach using anthracene-9-carboxylic acid and niflumic acid.

Authors:  C Altamura; G F Mangiatordi; O Nicolotti; D Sahbani; A Farinato; F Leonetti; M R Carratù; D Conte; J-F Desaphy; P Imbrici
Journal:  Br J Pharmacol       Date:  2018-04-06       Impact factor: 8.739

Review 5.  ClC-5 mutations associated with Dent's disease: a major role of the dimer interface.

Authors:  Stéphane Lourdel; Teddy Grand; Johanna Burgos; Wendy González; Francisco V Sepúlveda; Jacques Teulon
Journal:  Pflugers Arch       Date:  2011-11-15       Impact factor: 3.657

6.  Heterozygosity for an in-frame deletion causes glutaryl-CoA dehydrogenase deficiency in a patient detected by newborn screening: investigation of the effect of the mutant allele.

Authors:  Peter Bross; Jane B Frederiksen; Anne S Bie; Jakob Hansen; Johan Palmfeldt; Marit N Nielsen; Morten Duno; Allan M Lund; Ernst Christensen
Journal:  J Inherit Metab Dis       Date:  2012-01-10       Impact factor: 4.982

7.  Elevation of extracellular osmolarity improves signs of myotonia congenita in vitro: a preclinical animal study.

Authors:  Kerstin Hoppe; Sunisa Chaiklieng; Frank Lehmann-Horn; Karin Jurkat-Rott; Scott Wearing; Werner Klingler
Journal:  J Physiol       Date:  2018-11-20       Impact factor: 5.182

8.  Myotonia in DNM2-related centronuclear myopathy.

Authors:  Ron Dabby; Menachem Sadeh; Ronit Gilad; Karin Jurkat-Rott; Frank Lehmann-Horn; Esther Leshinsky-Silver
Journal:  J Neural Transm (Vienna)       Date:  2013-12-24       Impact factor: 3.575

9.  Angiotensin II modulates mouse skeletal muscle resting conductance to chloride and potassium ions and calcium homeostasis via the AT1 receptor and NADPH oxidase.

Authors:  Anna Cozzoli; Antonella Liantonio; Elena Conte; Maria Cannone; Ada Maria Massari; Arcangela Giustino; Antonia Scaramuzzi; Sabata Pierno; Paola Mantuano; Roberta Francesca Capogrosso; Giulia Maria Camerino; Annamaria De Luca
Journal:  Am J Physiol Cell Physiol       Date:  2014-07-30       Impact factor: 4.249

10.  Novel CLCN1 mutations and clinical features of Korean patients with myotonia congenita.

Authors:  In-Soo Moon; Hyang-Sook Kim; Jin-Hong Shin; Yeong-Eun Park; Kyu-Hyun Park; Yong-Bum Shin; Jong Seok Bae; Young-Chul Choi; Dae-Seong Kim
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.